Walvax Biotechnology Co., Ltd. (SHE:300142)

Walvax Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	18,456	37,601	64,274	89,423	59,516	49,874
Market Cap Growth	-37.47%	-41.50%	-28.12%	50.25%	19.33%	69.84%
Enterprise Value	17,699	36,117	62,959	88,584	58,587	48,620
Last Close Price	11.54	23.49	40.15	56.11	38.47	32.35
PE Ratio	150.82	89.66	88.21	209.06	59.33	351.29
Forward PE	67.88	42.75	54.68	56.13	42.78	94.72
PS Ratio	5.96	9.14	12.64	25.82	20.25	44.48
PB Ratio	1.92	3.30	5.85	8.94	7.58	8.80
P/TBV Ratio	2.76	4.57	8.15	11.16	9.54	10.60
P/FCF Ratio	113.35	199.74	582.65	-	-	-
P/OCF Ratio	28.29	33.16	53.50	126.79	521.18	804.21
EV/Sales Ratio	5.71	8.78	12.38	25.58	19.93	43.36
EV/EBITDA Ratio	25.40	35.24	44.27	95.49	51.04	195.96
EV/EBIT Ratio	50.81	49.15	53.63	111.82	57.22	283.54
EV/FCF Ratio	108.70	191.86	570.72	-	-	-
Debt / Equity Ratio	0.06	0.07	0.04	0.03	0.01	-
Debt / EBITDA Ratio	1.04	0.77	0.32	0.34	0.03	-
Debt / FCF Ratio	4.45	4.28	4.19	-	-	-
Asset Turnover	0.20	0.27	0.35	0.30	0.35	0.16
Inventory Turnover	0.74	0.74	0.72	0.60	1.02	0.86
Quick Ratio	2.69	2.38	2.24	2.07	3.00	2.86
Current Ratio	3.10	2.73	2.55	2.37	3.36	3.16
Return on Equity (ROE)	1.41%	4.57%	8.94%	6.74%	17.93%	3.55%
Return on Assets (ROA)	1.42%	2.97%	5.06%	4.25%	7.68%	1.50%
Return on Capital (ROIC)	1.77%	3.88%	6.74%	5.44%	9.44%	1.91%
Return on Capital Employed (ROCE)	2.80%	5.90%	9.90%	7.60%	12.50%	2.90%
Earnings Yield	0.66%	1.11%	1.13%	0.48%	1.69%	0.29%
FCF Yield	0.88%	0.50%	0.17%	-0.45%	-0.49%	-0.58%
Dividend Yield	0.09%	0.04%	0.03%	0.05%	0.18%	-
Payout Ratio	23.71%	4.76%	6.88%	19.48%	3.16%	48.38%
Buyback Yield / Dilution	1.45%	0.21%	-1.93%	-0.90%	-1.37%	-0.05%
Total Shareholder Return	1.54%	0.26%	-1.91%	-0.85%	-1.18%	-0.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.